Page 11 - Latest Updates on Coronavirus
Study on Covaxin should revise statement on conclusions for clarity
It likely overstates actual risks associated with the vaccine and conflates common illnesses with vaccine-related adverse effects
 "Study on Covaxin should revise statement on conclusions for clarity")
ICMR distances itself from BHU study on Covaxin, calls it 'poorly designed'
Bharat Biotech had then rebuked the BHU study, saying that its indigenously developed Covid vaccine Covaxin has shown an 'excellent safety track record' in various studies
 "ICMR distances itself from BHU study on Covaxin, calls it 'poorly designed'")
Covid vaccine makers gear up to launch new-generation jabs in India
India currently does not have any XBB 1.5 variant-based vaccines in the market
 "Covid vaccine makers gear up to launch new-generation jabs in India")
Federal Reserve Chair Powell tests positive for Covid-19: Spokesperson
Powell, 71, previously tested positive for Covid in January 2023. The next meeting of the Fed's policy-setting committee is set for June 11-12
 "Federal Reserve Chair Powell tests positive for Covid-19: Spokesperson")
Over 25,000 new Covid cases in Singapore, minister advises wearing masks
The Ministry of Health (MOH) said the estimated number of COVID-19 cases in the week of May 5 to 11 rose to 25,900 cases, compared with 13,700 cases in the previous week
 "Over 25,000 new Covid cases in Singapore, minister advises wearing masks")
Covaxin has 'excellent record', says Bharat Biotech after study cites risks
The research conducted by BHU indicated that Covaxin increased the rare risk of stroke and Guillain-Barre syndrome, among other issues
 "Covaxin has 'excellent record', says Bharat Biotech after study cites risks")
Lapses in BHU research on Covid-19 vaccine Covaxin, says Bharat Biotech
Nearly 363 mn doses of Covaxin have been administered in India so far, second only to AstraZeneca-Serum Institute of India's Covishield
 "Lapses in BHU research on Covid-19 vaccine Covaxin, says Bharat Biotech")
Over 30% Covaxin takers suffered from health issues after 1 year: BHU study
Nearly 50 per cent of 926 study participants in the study complained of infections during the follow-up period, predominated by viral upper respiratory tract infections
After Covishield, new study 'finds' side effects in Covaxin recipients
In observational study on Bharat Biotech's Covaxin recipients, about one-third of participants reported adverse events
Rare blood clots from J&J and AstraZeneca Covid shots linked to genetics
Out of more than 18 million people who received the single-dose J&J vaccine, 60 cases of the clotting disorder were reported and nine people died, according to the Yale School of Medicine
 "Rare blood clots from J&J and AstraZeneca Covid shots linked to genetics")
Reliance Retail Ventures plans expanding in diagnostic healthcare: Report
Company said to be considering acquiring majority stake in dedicated diagnostic services firm
 "Reliance Retail Ventures plans expanding in diagnostic healthcare: Report")
Does the country need to continue with Covid-19 vaccination drive?
Experts feel paid vaccine shots should continue to be available for elderly and comorbid
 "Does the country need to continue with Covid-19 vaccination drive?")
Pfizer, AstraZeneca announce new investments of nearly $1 bn in France
Their investment pledges came as President Emmanuel Macron prepared to kick off on Monday the annual 'Choose France' event aimed at wooing big overseas businesses and investors
 "Pfizer, AstraZeneca announce new investments of nearly $1 bn in France")
Nations struggle to draft pandemic treaty to avoid mistakes made in Covid
Britain's department of health said it would only agree to an accord if it was firmly in the UK national interest and respects national sovereignty
 "Nations struggle to draft pandemic treaty to avoid mistakes made in Covid")
Novavax signs Covid-19 license deal with Sanofi, secures business viability
Novavax said it would co-commercialize its Covid-19 vaccine with French drugmaker Sanofi and develop new Covid-19-influenza combination vaccines using Novavax's Matrix-M adjuvant
 "Novavax signs Covid-19 license deal with Sanofi, secures business viability")
Not producing, distributing Covishield since December 2021: Serum Institute
AstraZeneca Covid vaccine row: As of April 30, 2024, over 1.7 billion doses of the Covishield vaccine has been administered in India
 "Not producing, distributing Covishield since December 2021: Serum Institute")
Serum Institute responds for first time on Covishield amid safety row
Serum Institute of India says it stopped manufacturing Covishield since December 2021
 "Serum Institute responds for first time on Covishield amid safety row")
FLiRT 2024: New group of Covid variants spreads in US; all you need to know
FLiRT, a group of new Covid variants in the Omicron JN.1 lineage, is spreading in the US. KP.2 and KP 1.1 are more infectious than earlier Omicron variants, which, however, have similar side effects
 "FLiRT 2024: New group of Covid variants spreads in US; all you need to know")
Indian Embassy in China holds meeting with students hit by Covid visa bans
Around 80 old and new students from more than 13 Chinese universities took part in the welcome and interaction ceremony held on May 4
 "Indian Embassy in China holds meeting with students hit by Covid visa bans")
Covaxin developed with focus on safety first, says Bharat Biotech
In a statement, the company stated that Covaxin was developed with a single-minded focus on safety first, followed by efficacy
 "Covaxin developed with focus on safety first, says Bharat Biotech")
